Global 5-Azacytidine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global 5-Azacytidine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Azacitidine (5-azacytidine) is a chemical analogue of the cytosine nucleoside present in DNA and RNA. It induces antineoplastic activity by inhibiting DNA methyltransferase at low doses and inducing cytotoxicity by incorporating itself into RNA and DNA at high doses.
Global 5-Azacytidine market is projected to reach US$ 133.5 million in 2029, increasing from US$ 78 million in 2022, with the CAGR of 7.4% during the period of 2024 to 2029. Demand from Clinical and Non-clinical are the major drivers for the industry.
Azacitidine is an anticancer drug used to treat myelodysplastic syndrome (MDS), acute myeloid leukemia, and other cancers. Azacitidine promotes cell differentiation by affecting DNA methylation patterns involved in gene expression. It also inhibits telomerase activity, thereby inhibiting proliferation, which leads to apoptosis. This has led to its use not only in the treatment of myelodysplastic syndromes, but also in the treatment of various types of cancer, including leukemia, lymphoma, breast cancer, and more. Growth factors for the azacitidine market include increasing prevalence of blood disorders globally and technological advancements in healthcare. However, high cost associated with treatment may hamper the growth of the market to some extent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 5-Azacytidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Teva Pharmaceutical Industries
Tecoland
Intas Pharmaceuticals
Huzhou Zhanwang
Segment by Type
0.05g
0.1g
Others
Clinical
Non-clinical
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the 5-Azacytidine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 5-Azacytidine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 5-Azacytidine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of 5-Azacytidine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 5-Azacytidine introduction, etc. 5-Azacytidine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 5-Azacytidine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Global 5-Azacytidine market is projected to reach US$ 133.5 million in 2029, increasing from US$ 78 million in 2022, with the CAGR of 7.4% during the period of 2024 to 2029. Demand from Clinical and Non-clinical are the major drivers for the industry.
Azacitidine is an anticancer drug used to treat myelodysplastic syndrome (MDS), acute myeloid leukemia, and other cancers. Azacitidine promotes cell differentiation by affecting DNA methylation patterns involved in gene expression. It also inhibits telomerase activity, thereby inhibiting proliferation, which leads to apoptosis. This has led to its use not only in the treatment of myelodysplastic syndromes, but also in the treatment of various types of cancer, including leukemia, lymphoma, breast cancer, and more. Growth factors for the azacitidine market include increasing prevalence of blood disorders globally and technological advancements in healthcare. However, high cost associated with treatment may hamper the growth of the market to some extent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 5-Azacytidine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Teva Pharmaceutical Industries
Tecoland
Intas Pharmaceuticals
Huzhou Zhanwang
Segment by Type
0.05g
0.1g
Others
Segment by Application
Clinical
Non-clinical
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the 5-Azacytidine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 5-Azacytidine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 5-Azacytidine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of 5-Azacytidine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 5-Azacytidine introduction, etc. 5-Azacytidine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 5-Azacytidine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices